X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (115) 115
oncology (74) 74
female (63) 63
cost-benefit analysis (41) 41
index medicus (37) 37
male (35) 35
aged (34) 34
united states (31) 31
middle aged (29) 29
cancer (28) 28
chemotherapy (26) 26
registries (24) 24
medicare (23) 23
breast cancer (22) 22
neoplasms - therapy (21) 21
aged, 80 and over (19) 19
breast neoplasms - economics (18) 18
breast neoplasms - drug therapy (17) 17
positron-emission tomography (17) 17
prostate cancer (16) 16
therapy (16) 16
adult (15) 15
neoplasms - diagnostic imaging (15) 15
radiology, nuclear medicine & medical imaging (15) 15
treatment outcome (15) 15
prognosis (14) 14
care and treatment (13) 13
cohort studies (13) 13
decision support techniques (13) 13
neoplasm staging (13) 13
positron emission tomography (13) 13
breast-cancer (12) 12
survival (12) 12
cost-effectiveness (11) 11
efficacy (11) 11
health care costs (11) 11
management (11) 11
patients (11) 11
quality of life (11) 11
research (11) 11
sensitivity and specificity (11) 11
antineoplastic combined chemotherapy protocols - therapeutic use (10) 10
care (10) 10
impact (10) 10
medicine, general & internal (10) 10
surgery (10) 10
survival analysis (10) 10
survival rate (10) 10
antineoplastic agents - economics (9) 9
antineoplastic agents - therapeutic use (9) 9
breast neoplasm (9) 9
breast neoplasms - surgery (9) 9
breast neoplasms - therapy (9) 9
lung cancer (9) 9
neoplasm metastasis (9) 9
neoplasms - economics (9) 9
outcomes (9) 9
retrospective studies (9) 9
usage (9) 9
virginia (9) 9
women (9) 9
article (8) 8
bone neoplasms - secondary (8) 8
breast neoplasms - pathology (8) 8
colorectal cancer (8) 8
mortality (8) 8
pet (8) 8
physicians (8) 8
prospective studies (8) 8
time factors (8) 8
cell lung-cancer (7) 7
decision modeling (7) 7
decision trees (7) 7
decision-analysis (7) 7
markov chains (7) 7
palliative care (7) 7
quality-adjusted life years (7) 7
randomized-trial (7) 7
registry (7) 7
united states - epidemiology (7) 7
cancer therapies (6) 6
diphosphonates - therapeutic use (6) 6
fluorodeoxyglucose f18 (6) 6
health (6) 6
hospitals (6) 6
lung neoplasms - economics (6) 6
metastasis (6) 6
quality (6) 6
radiotherapy (6) 6
risk assessment (6) 6
surveys and questionnaires (6) 6
abridged index medicus (5) 5
age factors (5) 5
analysis (5) 5
antineoplastic agents, hormonal - therapeutic use (5) 5
breast neoplasms - mortality (5) 5
breast neoplasms - radiotherapy (5) 5
carcinoma, non-small-cell lung - drug therapy (5) 5
carcinoma, non-small-cell lung - economics (5) 5
clinical trials (5) 5
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of Nuclear Medicine, ISSN 0161-5505, 03/2018, Volume 59, Issue 3, p. 421
We have previously reported that PET with 18F-fluoride (NaF PET) for assessment of osseous metastatic disease led to changes in intended management in a... 
Health care | Deprivation | Medicare | Medical treatment | Lung cancer | Medical services | Positron emission | Management | Radiation therapy | Disease control | Patients | Metastases | Studies | Chemotherapy | Fluoride | Government programs | Surgery | Tomography | Prostate cancer | Prostate | Cancer
Journal Article
The Journal of Nuclear Medicine, ISSN 0161-5505, 03/2018, Volume 59, Issue 3, p. 427
We have previously reported that PET using 18F-fluoride (NaF PET) for assessment of osseous metastatic disease was associated with substantial changes in... 
Health care | Medical personnel | Prognosis | Medicare | Physicians | Indication | Medical treatment | Lung cancer | Medical services | Positron emission | Health risks | Breast cancer | Disease control | Patients | Survival | Metastases | Studies | Fluoride | Government programs | Palliative care | Tomography | Prostate | Prostate cancer | Cancer
Journal Article
The Journal of Nuclear Medicine, ISSN 0161-5505, 02/2015, Volume 56, Issue 2, p. 222
  In a national prospective registry, we previously studied the impact of ...-sodium fluoride PET (NaF PET) on the intended management of cancer patients with... 
Oncology | Disease management | Metastasis | Cancer therapies | Patients | Cancer
Journal Article
The Journal of Nuclear Medicine, ISSN 0161-5505, 04/2014, Volume 55, Issue 4, p. 574
  Under Medicare's Coverage with Evidence Development policy, PET using ...F-sodium fluoride (NaF PET) to identify osseous metastasis became a covered service... 
Mens health | Medical imaging | Physicians | Tomography | Oncology | Metastasis | Prostate cancer
Journal Article
JAMA - Journal of the American Medical Association, ISSN 0098-7484, 04/2019, Volume 321, Issue 13, pp. 1286 - 1294
Journal Article
The Journal of Nuclear Medicine, ISSN 0161-5505, 09/2013, Volume 54, Issue 9, p. 1518
  PET and PET/CT are widely used for surveillance of patients after cancer treatments. We conducted a systematic review to assess the diagnostic accuracy and... 
Surveillance | Medical treatment | Colorectal cancer | Clinical trials | Lymphomas | Head & neck cancer
Journal Article
The Journal of Nuclear Medicine, ISSN 0161-5505, 12/2013, Volume 54, Issue 12, p. 2024
  The National Oncologic PET Registry (NOPR) collected data on intended management before and after PET in cancer patients. We have previously reported that... 
Nuclear medicine | Medicare | Oncology | Patients | Cancer
Journal Article
The Journal of Nuclear Medicine, ISSN 0161-5505, 07/2014, Volume 55, Issue 7, p. 1054
  The National Oncologic PET Registry prospectively assessed the impact of PET with ^sup 18^F-sodium fluoride (NaF PET) on intended management of Medicare... 
Tomography | Oncology | Disease management | Cancer therapies | Social impact
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2001, Volume 19, Issue 11, pp. 2886 - 2897
Purpose: We describe the impact of clinical practice guidelines (CPGs) on improvement in oncology treatment processes or outcomes. Methods: We performed a... 
SURVIVAL | LUNG-CANCER | IMPACT | THERAPY | ONCOLOGY | PAIN MANAGEMENT | OUTCOMES | PATIENT-MANAGEMENT GUIDELINES | BREAST | PROGRAM | Length of Stay | Guideline Adherence | Outcome Assessment (Health Care) | Humans | Evidence-Based Medicine | Critical Pathways | Quality of Health Care | Patient Satisfaction | Practice Guidelines as Topic
Journal Article
The Journal of Nuclear Medicine, ISSN 0161-5505, 05/2012, Volume 53, Issue 5, p. 831
Since 2006, the National Oncologic PET Registry has collected prospective data on ^sup 18^F-FDG PET performed for cancer indications in Medicare beneficiaries... 
Chemotherapy | Medicare | Decision making | Physicians | Management decisions | Cancer therapies
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.